These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6816860)

  • 1. [Studies on Acinetobacter calcoaceticus. The virulence and the therapeutic efficacy of antibiotics in mice].
    Obana Y; Nishino T; Tanino T
    Kansenshogaku Zasshi; 1982 Sep; 56(9):753-61. PubMed ID: 6816860
    [No Abstract]   [Full Text] [Related]  

  • 2. In-vitro and in-vivo activities of antimicrobial agents against Acinetobacter calcoaceticus.
    Obana Y; Nishino T; Tanino T
    J Antimicrob Chemother; 1985 Apr; 15(4):441-8. PubMed ID: 4008377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensitivity of Acinetobacter calcoaceticus-baumanni complex and Acinetobacter lwoffi to common antibiotics].
    Reina J
    Enferm Infecc Microbiol Clin; 1991; 9(7):438-9. PubMed ID: 1799617
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acinetobacter calcoaceticus, a potential pathogen with an increasing role in pathology].
    Georgescu C; Neguţ M; Marinescu L; Călin C; Boboc F; Georgescu-Brăila M; Florescu DP; Trifan G
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1984; 29(4):333-9. PubMed ID: 6522946
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antibiotic sensitivity of Acinetobacter calcoaceticus in patients with infected burns].
    Borisova OK; Makarenkova RV; Bogatova IS; Kutsidi EV
    Antibiotiki; 1982 Jun; 27(6):447-50. PubMed ID: 7114831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concerning the sensitivity of Acinetobacter calcoaceticus.
    Jedlicková Z; Tesaríková E; Výmola F
    J Hyg Epidemiol Microbiol Immunol; 1990; 34(1):73-6. PubMed ID: 2351822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of nosocomial Acinetobacter anitratus strains to 13 antibiotics.
    Daschner F; Nopper S
    J Antimicrob Chemother; 1980 May; 6(3):415-6. PubMed ID: 7400077
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathogenic significance of Acinetobacter calcoaceticus: analysis of experimental infection in mice.
    Obana Y
    Microbiol Immunol; 1986; 30(7):645-57. PubMed ID: 3773789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Is sulbactam really the answer for treatment of infections caused by multiresistant strains of Acinetobacter spp.?].
    Casellas JM; Dana R
    Enferm Infecc Microbiol Clin; 1997; 15(6):335-6. PubMed ID: 9376409
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of reduced tigecycline susceptibility on clinical outcomes of Acinetobacter bacteremia.
    Chang YY; Liu YM; Liu CP; Kuo SC; Chen TL;
    J Microbiol Immunol Infect; 2018 Feb; 51(1):148-152. PubMed ID: 29050749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Problem of treatment for pyo-inflammatory complications caused by Acinetobacter].
    Bogomolova NS; Bol'shakov LV; Kuznetsova SM
    Anesteziol Reanimatol; 2014; (1):26-32. PubMed ID: 24749305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of Acinetobacter meningitis with meropenem and rifampicin.
    Gleeson T; Petersen K; Mascola J
    J Antimicrob Chemother; 2005 Sep; 56(3):602-3. PubMed ID: 16046467
    [No Abstract]   [Full Text] [Related]  

  • 13. Antimicrobial susceptibility of Acinetobacter strains identified by DNA-DNA hybridization.
    Tjernberg I
    APMIS; 1990 Apr; 98(4):320-6. PubMed ID: 2354051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic Resistance Pattern of Acinetobacter spp. Strains Isolated from Blood Infections in Shahid Sadoughi Hospital, Yazd, Iran.
    Atefi A; Ayatollahi J; Shahcheraghi SH; Mongabadi FD
    J Coll Physicians Surg Pak; 2017 Apr; 27(4):263. PubMed ID: 28492163
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acinetobacter, a nosocomial pathogen. Contribution of experimental models].
    Joly-Guillou ML; Hidri N; Wolff M
    Presse Med; 2002 Apr; 31(14):651-6. PubMed ID: 11995384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comment: tigecycline for the treatment of Acinetobacter infections: a case series.
    Curcio D
    Ann Pharmacother; 2008 Nov; 42(11):1717-8; author reply 1718. PubMed ID: 18827173
    [No Abstract]   [Full Text] [Related]  

  • 17. Infections with Acinetobacter calcoaceticus (Herellea vaginicola): clinical and laboratory studies.
    Glew RH; Moellering RC; Kunz LJ
    Medicine (Baltimore); 1977 Mar; 56(2):79-97. PubMed ID: 846390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the virulence potential of Acinetobacter strains from clinical and environmental sources.
    Tayabali AF; Nguyen KC; Shwed PS; Crosthwait J; Coleman G; Seligy VL
    PLoS One; 2012; 7(5):e37024. PubMed ID: 22655033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of acinetobacter strains isolated from deployed U.S. military personnel.
    Hawley JS; Murray CK; Griffith ME; McElmeel ML; Fulcher LC; Hospenthal DR; Jorgensen JH
    Antimicrob Agents Chemother; 2007 Jan; 51(1):376-8. PubMed ID: 17043112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and changing minimum inhibitory concentration (MIC) of Acinetobacter species from a tertiary care setup.
    Capoor MR; Nair D; Srivastava L; Gupta B; Aggarwal P
    J Commun Dis; 2005 Jun; 37(2):99-107. PubMed ID: 16749272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.